From Microsoft Buys LinkedIn for $26.2B in Mega Social-Business Deal:

Microsoft-Linkedin deal—

Microsoft announced the purchase of LinkedIn for $26.2 billion in cash on June 13, 2016. From left: LinkedIn CEO Jeff Weiner, Microsoft CEO Satya Nadella, LinkedIn co-founder Reid Hoffman. Photo courtesy of Microsoft.

Underwriters and Partners

Xconomy Insight

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Bio Roundup: Blackstone's Billions, Biogen Finishes Filing, Novavax at "Warp Speed" & More

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

From Microsoft Buys LinkedIn for $26.2B in Mega Social-Business Deal:

Underwriters and Partners

Robert Langer reveals secrets to early-stage biotech success

What to Include in Your Life Sciences Company Fundraising Pitch Deck

How to Approach Life Sciences Fundraising

Xconomy on Demand

We offer a number of ways to subscribe for free!